홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,3-Oxazol-2(5H)-one → 3-{3-Fluoro-4-[4-(5-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one

HRID 1804384
인쇄

반응식

HRID 1804384 반응식
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[C:4]([F:23])[CH:3]=1.[O:24]1[CH2:28][CH:27]=[N:26][C:25]1=[O:29]>>[F:23][C:4]1[CH:3]=[C:2]([N:26]2[CH2:27][CH2:28][O:24][C:25]2=[O:29])[CH:7]=[CH:6][C:5]=1[C:8]([N:10]1[CH2:15][CH2:14][N:13]([C:16]2[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][N:17]=2)[CH2:12][CH2:11]1)=[O:9]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 144050941,3-Oxazol-2(5H)-oneHCID 58484600(4-Bromo-2-fluorophenyl)[4-(5-methylpyridin-2-yl)piperazin-1-yl]methanone

생성물 1

HCID 584845103-{3-Fluoro-4-[4-(5-methylpyridin-2-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one수율 68.7%

실험 절차

By reaction and treatment in the same manner as in Example 110 and using (4-bromo-2-fluorophenyl)[4-(5-methylpyridin-2-yl)piperazin-1-yl]methanone (378 mg) described in Preparation Example 184 and oxazolin-2-one (104 mg), the title compound (264 mg) was obtained.

후처리

  1. customBy reaction and treatment in the same manner as in Example 110

출처 및 근거

ORD 기록
ord-7eebafab92ca4215a7a77cde0b9dc287
출처 데이터셋
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08354401B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트